The Differences in the Psychological States of Patients with Different Chronic Hip Pain
Launched by CHUNBAO LI · Sep 22, 2024
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The subject must be at least 16 years old and of sound mind；
- • Chronic hip pain persisting for a duration exceeding 3 months.
- Exclusion Criteria:
- • Previous mental illness and cognitive impairment；
- • Other serious illnesses such as heart failure, respiratory failure, malignant tumours, severe trauma and other serious illnesses;；
- • Chronic pain lasting for more than 3 months in other parts of the body;；
- • Use of prescribed opioid drugs exceeding 60 mg morphine equivalent per day or steroid analgesics.
About Chunbao Li
Chunbao Li is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong focus on developing novel therapeutic solutions, Chunbao Li collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials. The organization prioritizes patient safety and ethical standards while striving to bring impactful treatments to market, ultimately enhancing patient care and outcomes. Through its strategic partnerships and commitment to scientific excellence, Chunbao Li plays a vital role in the evolution of healthcare and the betterment of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Chunbao Li
Study Director
The Fourth Medical Centre of the General Hospital of the People's Liberation Army
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported